US4379454A
(en)
*
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
US4460372A
(en)
*
|
1981-02-17 |
1984-07-17 |
Alza Corporation |
Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer
|
JPS6059207B2
(ja)
*
|
1981-03-13 |
1985-12-24 |
日東電工株式会社 |
複合製剤の製法
|
US4954344A
(en)
*
|
1981-06-29 |
1990-09-04 |
Alza Corporation |
Method for treating nocturnal angina
|
US4849226A
(en)
*
|
1981-06-29 |
1989-07-18 |
Alza Corporation |
Method for increasing oxygen supply by administering vasodilator
|
US4834979A
(en)
*
|
1981-06-29 |
1989-05-30 |
Alza Corporation |
Medical bandage for administering beneficial drug
|
US4812313A
(en)
*
|
1981-06-29 |
1989-03-14 |
Alza Corporation |
Method for lessening the incidence of anginal attacks
|
US4661105A
(en)
*
|
1981-06-29 |
1987-04-28 |
Alza Corporation |
Medical bandage for administering vasodilator drug
|
US4725272A
(en)
*
|
1981-06-29 |
1988-02-16 |
Alza Corporation |
Novel bandage for administering beneficial drug
|
GB2105990B
(en)
*
|
1981-08-27 |
1985-06-19 |
Nitto Electric Ind Co |
Adhesive skin patches
|
US4460368A
(en)
*
|
1981-10-29 |
1984-07-17 |
Almedco, Inc. |
Trans-dermal medication system
|
US4532937A
(en)
*
|
1982-12-28 |
1985-08-06 |
Cuderm Corporation |
Sebum collection and monitoring means and method
|
US4681544A
(en)
*
|
1983-01-13 |
1987-07-21 |
Anthony Albert J |
Oral pack retention system
|
FR2542998B1
(fr)
*
|
1983-03-24 |
1986-01-31 |
Rhone Poulenc Sante |
Nouvelle forme transdermale du dinitrate d'isosorbide
|
DE3315272C2
(de)
*
|
1983-04-27 |
1986-03-27 |
Lohmann Gmbh & Co Kg, 5450 Neuwied |
Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
|
US4564364A
(en)
*
|
1983-05-26 |
1986-01-14 |
Alza Corporation |
Active agent dispenser
|
JPS6016916A
(ja)
*
|
1983-07-08 |
1985-01-28 |
Nitto Electric Ind Co Ltd |
生物活性物質含有基剤及び該基剤の製法
|
DE3344691A1
(de)
*
|
1983-12-10 |
1985-06-20 |
Bayer Ag, 5090 Leverkusen |
Wirkstoffabgasesysteme
|
DE3347277A1
(de)
*
|
1983-12-28 |
1985-07-11 |
Bayer Ag, 5090 Leverkusen |
Wirkstoffabgabesysteme
|
DK149601C
(da)
*
|
1984-01-23 |
1987-02-02 |
Coloplast As |
Trykaflastende bandage
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
US4725439A
(en)
*
|
1984-06-29 |
1988-02-16 |
Alza Corporation |
Transdermal drug delivery device
|
US4655768A
(en)
*
|
1984-07-06 |
1987-04-07 |
Avery International Corporation |
Bandage for sustained delivery of drugs
|
WO1986000536A1
(en)
*
|
1984-07-06 |
1986-01-30 |
Avery International Corporation |
Bandage for sustained delivery of drugs
|
IL72684A
(en)
*
|
1984-08-14 |
1989-02-28 |
Israel State |
Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
US4605399A
(en)
*
|
1984-12-04 |
1986-08-12 |
Complex, Inc. |
Transdermal infusion device
|
US4752478A
(en)
*
|
1984-12-17 |
1988-06-21 |
Merck & Co., Inc. |
Transdermal system for timolol
|
US4883669A
(en)
*
|
1985-02-25 |
1989-11-28 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
|
EP0196769B1
(de)
*
|
1985-02-25 |
1992-07-08 |
Rutgers, The State University of New Jersey |
Dosierungssystem für transdermale Absorption von Arzneimittelwirkstoffen
|
DE3518707A1
(de)
*
|
1985-05-24 |
1986-11-27 |
Beiersdorf Ag, 2000 Hamburg |
Nitro-pflaster
|
EP0204968B1
(de)
*
|
1985-05-24 |
1989-09-27 |
Beiersdorf Aktiengesellschaft |
Nitro-Pflaster
|
US4690683A
(en)
*
|
1985-07-02 |
1987-09-01 |
Rutgers, The State University Of New Jersey |
Transdermal varapamil delivery device
|
EP0238554A4
(de)
*
|
1985-09-27 |
1987-10-27 |
Univ California |
Liposomensystem zur transdermalen arzneimittelverabreichung.
|
JPH0742228B2
(ja)
*
|
1985-11-13 |
1995-05-10 |
日東電工株式会社 |
医薬製剤
|
US4797284A
(en)
*
|
1986-03-12 |
1989-01-10 |
Merck & Co., Inc. |
Transdermal drug delivery system
|
US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
US4784857A
(en)
*
|
1986-06-03 |
1988-11-15 |
Smith And Nephew Associated Companies Plc |
Drug delivery device, its preparation and use
|
US4738257A
(en)
*
|
1986-06-11 |
1988-04-19 |
Hollister Incorporated |
Occlusive wound care dressing
|
DE3775830D1
(de)
*
|
1986-06-13 |
1992-02-20 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
EP0258521B1
(de)
*
|
1986-08-23 |
1990-05-02 |
Arno Walter Latzke |
Mittel zur Applikation von transdermal resorbierbaren Wirkstoffen
|
US5820876A
(en)
*
|
1986-08-28 |
1998-10-13 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system
|
USRE37934E1
(en)
|
1986-08-28 |
2002-12-10 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system
|
US6117448A
(en)
*
|
1986-08-28 |
2000-09-12 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6126963A
(en)
|
1986-08-28 |
2000-10-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6110488A
(en)
*
|
1986-08-28 |
2000-08-29 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6139868A
(en)
*
|
1986-08-28 |
2000-10-31 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US4938759A
(en)
*
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
CH672888A5
(de)
*
|
1986-11-07 |
1990-01-15 |
Mepha Ag |
|
US4909244B1
(en)
*
|
1986-11-26 |
1994-07-05 |
Kendall & Co |
Hydrogel wound dressing
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
US4906169A
(en)
*
|
1986-12-29 |
1990-03-06 |
Rutgers, The State University Of New Jersey |
Transdermal estrogen/progestin dosage unit, system and process
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US4816258A
(en)
*
|
1987-02-26 |
1989-03-28 |
Alza Corporation |
Transdermal contraceptive formulations
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5171576A
(en)
*
|
1987-03-09 |
1992-12-15 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5049387A
(en)
*
|
1987-03-09 |
1991-09-17 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5000956A
(en)
*
|
1987-03-09 |
1991-03-19 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5077054A
(en)
*
|
1987-03-09 |
1991-12-31 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5118509A
(en)
*
|
1987-03-09 |
1992-06-02 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
JPH0696529B2
(ja)
*
|
1987-03-31 |
1994-11-30 |
積水化学工業株式会社 |
ニトログリセリン貼付剤およびその製造方法
|
IL86170A
(en)
*
|
1987-05-01 |
1992-12-01 |
Elan Transdermal Ltd |
Preparations and compositions comprising nicotine for percutaneous administration
|
US4787888A
(en)
*
|
1987-06-01 |
1988-11-29 |
University Of Connecticut |
Disposable piezoelectric polymer bandage for percutaneous delivery of drugs and method for such percutaneous delivery (a)
|
US5549924A
(en)
*
|
1987-07-17 |
1996-08-27 |
Robin Renee Thill Shlenker |
Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
|
US5679399A
(en)
*
|
1987-07-17 |
1997-10-21 |
Bio Barrier, Inc. |
Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
US4915948A
(en)
*
|
1987-08-31 |
1990-04-10 |
Warner-Lambert Company |
Tablets having improved bioadhesion to mucous membranes
|
US5059189A
(en)
*
|
1987-09-08 |
1991-10-22 |
E. R. Squibb & Sons, Inc. |
Method of preparing adhesive dressings containing a pharmaceutically active ingredient
|
US4898920A
(en)
*
|
1987-10-15 |
1990-02-06 |
Dow Corning Corporation |
Adhesive compositions, controlled release compositions and transdermal delivery device
|
US5035894A
(en)
*
|
1987-10-15 |
1991-07-30 |
Dow Corning Corporation |
Controlled release compositions and transdermal drug delivery device
|
US4917895A
(en)
*
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4812305A
(en)
*
|
1987-11-09 |
1989-03-14 |
Vocal Rodolfo S |
Well medicine strip
|
US4781924A
(en)
*
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4837027A
(en)
*
|
1987-11-09 |
1989-06-06 |
Alza Corporation |
Transdermal drug delivery device
|
US4978391A
(en)
*
|
1987-11-13 |
1990-12-18 |
Dentsply Management Corp. |
Intraoral medicament delivery and procedure
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US4885154A
(en)
*
|
1988-03-01 |
1989-12-05 |
Alza Corporation |
Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
JPH0725669B2
(ja)
*
|
1988-12-23 |
1995-03-22 |
日東電工株式会社 |
経皮投与用医薬製剤
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5091186A
(en)
*
|
1989-08-15 |
1992-02-25 |
Cygnus Therapeutic Systems |
Biphasic transdermal drug delivery device
|
US5271940A
(en)
*
|
1989-09-14 |
1993-12-21 |
Cygnus Therapeutic Systems |
Transdermal delivery device having delayed onset
|
WO1991003998A1
(en)
*
|
1989-09-14 |
1991-04-04 |
Cygnus Research Corporation |
Transdermal delivery device having delayed onset
|
US5324521A
(en)
*
|
1989-12-18 |
1994-06-28 |
Dermamed |
Systems for transdermal administration of medicaments
|
JPH07116032B2
(ja)
*
|
1990-04-06 |
1995-12-13 |
積水化学工業株式会社 |
ニトログリセリン貼付剤
|
US5508038A
(en)
*
|
1990-04-16 |
1996-04-16 |
Alza Corporation |
Polyisobutylene adhesives for transdermal devices
|
US5160741A
(en)
*
|
1990-07-06 |
1992-11-03 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5130139A
(en)
*
|
1990-07-06 |
1992-07-14 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5120545A
(en)
*
|
1990-08-03 |
1992-06-09 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5149539A
(en)
*
|
1990-08-03 |
1992-09-22 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5173302A
(en)
*
|
1990-09-28 |
1992-12-22 |
Medtronic, Inc. |
Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
|
US5320850A
(en)
*
|
1990-10-29 |
1994-06-14 |
Alza Corporation |
Transdermal delivery of the gestogen ST-1435 and devices therefor
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5314694A
(en)
*
|
1990-10-29 |
1994-05-24 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5198223A
(en)
*
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
PT99338A
(pt)
*
|
1990-10-29 |
1992-10-30 |
Alza Corp |
Processo para a preparacao de composicoes de farmacos anticoncepcionais administradas transdermicamente contendo uma mistura dum estrogeno e gestodeno e dispositivos para a sua administracao transdermica
|
US5240917A
(en)
*
|
1991-04-03 |
1993-08-31 |
Keimowitz Rudolph M |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
US5203768A
(en)
*
|
1991-07-24 |
1993-04-20 |
Alza Corporation |
Transdermal delivery device
|
US5464387A
(en)
*
|
1991-07-24 |
1995-11-07 |
Alza Corporation |
Transdermal delivery device
|
US5234690A
(en)
*
|
1991-08-23 |
1993-08-10 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
|
US5273756A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
|
US5273755A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
|
US5189986A
(en)
*
|
1991-09-23 |
1993-03-02 |
Alza Corporation |
Veterinary transdermal active agent delivery device
|
ZA928011B
(en)
*
|
1991-10-18 |
1993-06-23 |
Alza Corp |
Transdermal administration of melatonin.
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
WO1993023025A1
(en)
*
|
1992-05-13 |
1993-11-25 |
Alza Corporation |
Transdermal administration of oxybutynin
|
US6071896A
(en)
*
|
1992-06-16 |
2000-06-06 |
Gundersen Clinic, Ltd. |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
AU7396294A
(en)
*
|
1993-06-25 |
1995-01-24 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
US5691377A
(en)
*
|
1993-07-30 |
1997-11-25 |
University Of Maryland Eastern Shore And University Of Maryland College Park |
Use of N-methyl-aspartic acid for enhancing growth and altering body composition
|
DE4332093C2
(de)
*
|
1993-09-22 |
1995-07-13 |
Lohmann Therapie Syst Lts |
Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
|
EP0721348B1
(de)
*
|
1993-09-29 |
1999-09-01 |
Alza Corporation |
Hautpermeabilitaetserhöher bestehend aus monoglycerid/laktat estern
|
DE4341444C2
(de)
*
|
1993-12-04 |
1996-03-14 |
Lohmann Therapie Syst Lts |
Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
|
US5505958A
(en)
*
|
1994-10-31 |
1996-04-09 |
Algos Pharmaceutical Corporation |
Transdermal drug delivery device and method for its manufacture
|
DE19517145C2
(de)
*
|
1995-05-10 |
2000-02-24 |
Hexal Pharmaforschung Gmbh |
Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5658583A
(en)
*
|
1995-07-28 |
1997-08-19 |
Zhang; Jie |
Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
|
US6245347B1
(en)
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US20040265353A1
(en)
*
|
1995-07-28 |
2004-12-30 |
Zars, Inc. |
Systems and methods for treating panic attacks
|
US6284266B1
(en)
|
1995-07-28 |
2001-09-04 |
Zars, Inc. |
Methods and apparatus for improved administration of fentanyl and sufentanil
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
US6512010B1
(en)
*
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US5955097A
(en)
*
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
ATE229817T1
(de)
*
|
1996-10-24 |
2003-01-15 |
Alza Corp |
Penetrationsfördernde substanzen für die transdermale verabreichung von wirkstoffen, vorrichtungen und verfahren zur herstellung
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
WO1999032153A1
(en)
|
1997-12-22 |
1999-07-01 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
US6269820B1
(en)
|
1998-02-26 |
2001-08-07 |
Xomed Surgical Products, Inc. |
Method of controlling post-operative leakage associated with tumescent liposuction
|
US6103266A
(en)
*
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US7662409B2
(en)
*
|
1998-09-25 |
2010-02-16 |
Gel-Del Technologies, Inc. |
Protein matrix materials, devices and methods of making and using thereof
|
US20050147690A1
(en)
*
|
1998-09-25 |
2005-07-07 |
Masters David B. |
Biocompatible protein particles, particle devices and methods thereof
|
AU6406299A
(en)
*
|
1998-09-29 |
2000-04-17 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US6726673B1
(en)
|
1999-05-24 |
2004-04-27 |
Zars, Inc. |
Methods and apparatus for improved administration of testosterone pharmaceuticals
|
US6955819B2
(en)
|
1998-09-29 |
2005-10-18 |
Zars, Inc. |
Methods and apparatus for using controlled heat to regulate transdermal and controlled release delivery of fentanyl, other analgesics, and other medical substances
|
AU1617800A
(en)
*
|
1998-11-12 |
2000-05-29 |
Polymer Biosciences, Inc. |
Hemostatic polymer useful for rapid blood coagulation and hemostasis
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
PT1140039E
(pt)
|
1998-12-18 |
2010-02-03 |
Alza Corp |
Dispositivos transparentes de administração transdérmica de nicotina
|
EP2305324B1
(de)
*
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medizinische Geräte und Anwendungen aus Polyhydroxyalkanoat-Polymeren
|
EP1169025B1
(de)
*
|
1999-04-01 |
2005-08-24 |
Alza Corporation |
Transdermale vorrichtung zur arzneistoffverabreichung mit einem polyurethanwirkstoffreservoir
|
US6453648B1
(en)
|
1999-07-06 |
2002-09-24 |
Zars, Inc. |
Method for manufacturing a heat generating apparatus
|
AU780953B2
(en)
|
1999-08-30 |
2005-04-28 |
Tepha, Inc. |
Flushable disposable polymeric products
|
US6432415B1
(en)
|
1999-12-17 |
2002-08-13 |
Axrix Laboratories, Inc. |
Pharmaceutical gel and aerosol formulations and methods to administer the same to skin and mucosal surfaces
|
US6261595B1
(en)
|
2000-02-29 |
2001-07-17 |
Zars, Inc. |
Transdermal drug patch with attached pocket for controlled heating device
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US20060073174A1
(en)
*
|
2001-08-16 |
2006-04-06 |
Access Pharmaceuticals, Inc. |
Adherent and erodible film to treat a moist surface of a body tissue
|
US6585997B2
(en)
|
2001-08-16 |
2003-07-01 |
Access Pharmaceuticals, Inc. |
Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
|
WO2003092468A2
(en)
*
|
2002-04-29 |
2003-11-13 |
Gel-Del Technologies, Inc. |
Biomatrix structural containment and fixation systems and methods of use thereof
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
US8034270B2
(en)
|
2003-05-08 |
2011-10-11 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
US8465537B2
(en)
*
|
2003-06-17 |
2013-06-18 |
Gel-Del Technologies, Inc. |
Encapsulated or coated stent systems
|
US7375139B2
(en)
*
|
2003-08-18 |
2008-05-20 |
Aldred Katherine M |
Transdermal method and apparatus
|
JP2007503221A
(ja)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
ポリヒドロキシアルカノエート神経再生デバイス
|
EP1660013A4
(de)
|
2003-08-26 |
2011-07-20 |
Gel Del Technologies Inc |
Protein-biomaterialien und biokoazervate und herstellungs- und verwendungsverfahren dafür
|
US8529939B2
(en)
|
2003-12-08 |
2013-09-10 |
Gel-Del Technologies, Inc. |
Mucoadhesive drug delivery devices and methods of making and using thereof
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US9205062B2
(en)
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050202073A1
(en)
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
WO2005107834A1
(en)
|
2004-04-30 |
2005-11-17 |
Clawson Burrell E |
Apparatus and methods for isolating human body areas for localized cooling
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
PT1778305E
(pt)
*
|
2004-08-03 |
2010-07-27 |
Tepha Inc |
Suturas de poli-hidroxialcanoato que no se enrolam
|
DE602006016915D1
(de)
*
|
2005-01-28 |
2010-10-28 |
Tepha Inc |
Embolisierung unter verwendung von poly-4-hydroxybutyrat-partikeln
|
US8632800B2
(en)
|
2005-05-13 |
2014-01-21 |
Alza Corporation |
Multilayer drug delivery system with barrier against reservoir material flow
|
WO2007035942A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal risperidone delivery system
|
WO2007035940A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal norelgestromin delivery system
|
US20070104771A1
(en)
*
|
2005-09-23 |
2007-05-10 |
Jay Audett |
Transdermal galantamine delivery system
|
EP2308480B1
(de)
|
2005-09-23 |
2014-08-13 |
ALZA Corporation |
Polyacrylatformulierung mit hoher Beladung von verstärkenden Substanzen für transdermale Anwendungen
|
GB0606661D0
(en)
*
|
2006-04-03 |
2006-05-10 |
Brightwake Ltd |
Improvements relating to dressings
|
US8518926B2
(en)
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
US20070248653A1
(en)
*
|
2006-04-20 |
2007-10-25 |
Cochrum Kent C |
Hemostatic compositions and methods for controlling bleeding
|
AU2007253899A1
(en)
*
|
2006-05-16 |
2007-11-29 |
Knopp Neurosciences, Inc. |
Compositions of R(+) and S(-) pramipexole and methods of using the same
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
CN103550136B
(zh)
|
2006-07-21 |
2016-04-13 |
生物递送科学国际公司 |
吸收增强的经粘膜递送装置
|
SI2068918T1
(sl)
|
2006-09-26 |
2012-09-28 |
Infectious Disease Res Inst |
Si - ep sestavek za cepljenje, ki vsebuje sintetiäśna pomagala
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
US7943683B2
(en)
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
RU2454409C2
(ru)
|
2007-03-14 |
2012-06-27 |
Нопп Ньюросайенсиз, Инк. |
Синтез хирально очищенных замещенных бензотиазолдиаминов
|
WO2008116004A2
(en)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
WO2009086483A2
(en)
*
|
2007-12-26 |
2009-07-09 |
Gel-Del Technologies, Inc. |
Biocompatible protein particles, particle devices and methods thereof
|
JP5552255B2
(ja)
|
2008-04-16 |
2014-07-16 |
日東電工株式会社 |
薬物経皮投与デバイス
|
GB0809131D0
(en)
*
|
2008-05-20 |
2008-06-25 |
Brightwake Ltd |
Soft silicones tapes
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
CA2734491A1
(en)
|
2008-08-19 |
2010-02-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (r)-pramipexole
|
US10016534B2
(en)
|
2008-11-17 |
2018-07-10 |
Gel-Del Technologies, Inc. |
Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof
|
US9012477B2
(en)
*
|
2009-01-06 |
2015-04-21 |
Nuvo Research Inc. |
Method of treating neuropathic pain
|
JP4934163B2
(ja)
*
|
2009-03-18 |
2012-05-16 |
オカモト株式会社 |
皮膚貼付積層体
|
WO2010114973A1
(en)
*
|
2009-04-01 |
2010-10-07 |
Jie Zhang |
Methods for treating myofascial, muscle, and/or back pain
|
EP2419085A4
(de)
*
|
2009-04-14 |
2013-04-24 |
Univ California |
Verbesserte vorrichtungen für orale arzneimittel und arzneiformen
|
AU2010246064A1
(en)
*
|
2009-05-04 |
2011-12-22 |
Zars Pharma, Inc. |
Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
|
US9186334B2
(en)
|
2009-05-04 |
2015-11-17 |
Nuvo Research Inc. |
Heat assisted lidocaine and tetracaine for transdermal analgesia
|
RU2732574C2
(ru)
|
2009-06-05 |
2020-09-21 |
Инфекшес Дизиз Рисерч Инститьют |
Синтетические глюкопиранозиллипидные адъюванты
|
AU2010262970A1
(en)
*
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
US8701671B2
(en)
|
2011-02-04 |
2014-04-22 |
Joseph E. Kovarik |
Non-surgical method and system for reducing snoring
|
US9549842B2
(en)
|
2011-02-04 |
2017-01-24 |
Joseph E. Kovarik |
Buccal bioadhesive strip and method of treating snoring and sleep apnea
|
CA2689400C
(en)
*
|
2009-12-30 |
2023-01-10 |
Kenneth W. Adams |
Therapeutic agent delivery apparatus and process
|
MX2012008168A
(es)
|
2010-01-14 |
2013-02-07 |
Nuvo Res Inc |
Formulaciones anestesicas locales que forman solidos para control del dolor.
|
US9327105B2
(en)
*
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
AU2012205791B2
(en)
|
2011-01-10 |
2016-11-03 |
Invion, Ltd. |
Use of beta-adrenergic inverse agonists for smoking cessation
|
US11998479B2
(en)
|
2011-02-04 |
2024-06-04 |
Seed Health, Inc. |
Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
CA2832307A1
(en)
|
2011-04-08 |
2012-10-18 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
US8388569B2
(en)
*
|
2011-04-19 |
2013-03-05 |
Xerox Corporation |
Delivery devices and methods with collimated gas stream and particle source
|
ES2660116T3
(es)
|
2011-08-18 |
2018-03-20 |
Biodelivery Sciences International, Inc. |
Dispositivos mucoadhesivos resistentes al uso inadecuado para la administración de buprenorfina
|
GB2493960B
(en)
|
2011-08-25 |
2013-09-18 |
Brightwake Ltd |
Non-adherent wound dressing
|
US9700245B2
(en)
|
2011-09-23 |
2017-07-11 |
Itrace Biomedical Inc. |
Transdermal analyte extraction and detection system and the method thereof
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
CN110339160A
(zh)
|
2012-02-07 |
2019-10-18 |
传染性疾病研究院 |
包含tlr4激动剂的改进佐剂制剂及其使用方法
|
NZ701881A
(en)
|
2012-05-16 |
2016-10-28 |
Immune Design Corp |
Vaccines for hsv-2
|
FR2992325B1
(fr)
*
|
2012-06-26 |
2015-05-22 |
Ab7 Innovation |
Matrice sequencee multifonctionnelle monopolymerique en polyurethane coule et procede de fabrication
|
US10179239B2
(en)
|
2013-01-15 |
2019-01-15 |
Itrace Biomedical Inc. |
Personalized pain management treatments
|
US9710607B2
(en)
|
2013-01-15 |
2017-07-18 |
Itrace Biomedical Inc. |
Portable electronic therapy device and the method thereof
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
AU2014253791B2
(en)
|
2013-04-18 |
2019-05-02 |
Immune Design Corp. |
GLA monotherapy for use in cancer treatment
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
CN105764507B
(zh)
|
2013-07-12 |
2019-07-19 |
诺普生物科学有限责任公司 |
治疗升高的嗜酸性粒细胞和/或嗜碱性粒细胞的水平
|
ES2871556T3
(es)
|
2013-08-13 |
2021-10-29 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de la urticaria crónica
|
AU2014306683B2
(en)
|
2013-08-13 |
2017-10-12 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
|
US12005085B2
(en)
|
2013-12-20 |
2024-06-11 |
Seed Health, Inc. |
Probiotic method and composition for maintaining a healthy vaginal microbiome
|
US11969445B2
(en)
|
2013-12-20 |
2024-04-30 |
Seed Health, Inc. |
Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11998574B2
(en)
|
2013-12-20 |
2024-06-04 |
Seed Health, Inc. |
Method and system for modulating an individual's skin microbiome
|
US11980643B2
(en)
|
2013-12-20 |
2024-05-14 |
Seed Health, Inc. |
Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
EP2889030A1
(de)
|
2013-12-30 |
2015-07-01 |
Uluru Inc. |
Steuerung der Erosionsraten von mukoadhäsiven Vorrichtungen mit Lieferung von Wirkstoffen und anderen Verbindungen und Bereitstellung erhöhter und unterschiedlicher therapeutischer Blutwerte
|
CN105960241A
(zh)
|
2014-01-21 |
2016-09-21 |
免疫设计公司 |
用于治疗过敏性病症的组合物
|
EP3180040B1
(de)
|
2014-08-15 |
2020-05-13 |
Tepha, Inc. |
Selbsthaltendes chirurgisches nahtmaterial aus poly-4-hydroxybutyrat und copolymeren davon
|
EP3230500A1
(de)
|
2014-12-11 |
2017-10-18 |
Tepha, Inc. |
Verfahren zur ausrichtung von multifilamentgarn und monofilamenten aus poly-4-hydroxybutyrat und copolymere davon
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
MX2018013640A
(es)
|
2016-05-16 |
2019-08-01 |
Infectious Disease Res Inst |
Liposomas pegiladas y metodos de uso.
|
ES2929054T3
(es)
|
2016-05-16 |
2022-11-24 |
Access To Advanced Health Inst |
Formulación que contiene un agonista de TLR y métodos de uso
|
KR20220165789A
(ko)
|
2016-06-01 |
2022-12-15 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사이징제를 함유하는 나노명반 입자
|
WO2018231706A1
(en)
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
US20210137727A1
(en)
*
|
2017-08-01 |
2021-05-13 |
Rechargeable Battery Corporation |
Porous oxygen activated heater configurations, designs and applications
|
CA3173408A1
(en)
|
2020-12-23 |
2022-06-30 |
Access To Advanced Health Institute |
Solanesol vaccine adjuvants and methods of preparing same
|